nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ABCC3—Rifampicin—leprosy	0.158	0.202	CbGbCtD
Methotrexate—SLCO1B3—Rifampicin—leprosy	0.14	0.179	CbGbCtD
Methotrexate—SLC22A7—Rifampicin—leprosy	0.124	0.158	CbGbCtD
Methotrexate—ABCC1—Rifampicin—leprosy	0.0971	0.124	CbGbCtD
Methotrexate—SLCO1A2—Rifampicin—leprosy	0.0867	0.111	CbGbCtD
Methotrexate—SLCO1B1—Rifampicin—leprosy	0.0818	0.104	CbGbCtD
Methotrexate—ABCC2—Rifampicin—leprosy	0.0719	0.0918	CbGbCtD
Methotrexate—ABCB1—Rifampicin—leprosy	0.0234	0.0299	CbGbCtD
Methotrexate—ATIC—pes—leprosy	0.0131	0.158	CbGeAlD
Methotrexate—Pneumocystis jirovecii pneumonia—Thalidomide—leprosy	0.00689	0.0523	CcSEcCtD
Methotrexate—ATIC—hindlimb—leprosy	0.00595	0.0718	CbGeAlD
Methotrexate—ATIC—appendage—leprosy	0.0051	0.0616	CbGeAlD
Methotrexate—Mood alteration NOS—Thalidomide—leprosy	0.0043	0.0327	CcSEcCtD
Methotrexate—ATIC—skin epidermis—leprosy	0.00425	0.0512	CbGeAlD
Methotrexate—Anaemia megaloblastic—Thalidomide—leprosy	0.00366	0.0278	CcSEcCtD
Methotrexate—Arterial thrombosis—Thalidomide—leprosy	0.00321	0.0244	CcSEcCtD
Methotrexate—Leukaemia—Thalidomide—leprosy	0.00321	0.0244	CcSEcCtD
Methotrexate—Thromboembolic event—Thalidomide—leprosy	0.00321	0.0244	CcSEcCtD
Methotrexate—Tumour lysis syndrome—Thalidomide—leprosy	0.00311	0.0236	CcSEcCtD
Methotrexate—FOLR1—eye—leprosy	0.00268	0.0323	CbGeAlD
Methotrexate—Skin necrosis—Thalidomide—leprosy	0.00247	0.0188	CcSEcCtD
Methotrexate—TYMS—Menadione—Thalidomide—leprosy	0.00228	1	CbGdCrCtD
Methotrexate—Intestinal perforation—Thalidomide—leprosy	0.00218	0.0166	CcSEcCtD
Methotrexate—MTHFR—blood vessel—leprosy	0.00211	0.0255	CbGeAlD
Methotrexate—Rales—Thalidomide—leprosy	0.0021	0.016	CcSEcCtD
Methotrexate—Dementia—Thalidomide—leprosy	0.0021	0.016	CcSEcCtD
Methotrexate—Pericarditis—Thalidomide—leprosy	0.002	0.0152	CcSEcCtD
Methotrexate—Proteinuria—Dapsone—leprosy	0.00192	0.0146	CcSEcCtD
Methotrexate—Protein urine present—Dapsone—leprosy	0.00189	0.0144	CcSEcCtD
Methotrexate—Raised liver function tests—Thalidomide—leprosy	0.00187	0.0142	CcSEcCtD
Methotrexate—Neck stiffness—Thalidomide—leprosy	0.00181	0.0138	CcSEcCtD
Methotrexate—SLC46A1—eye—leprosy	0.00181	0.0218	CbGeAlD
Methotrexate—Nuchal rigidity—Thalidomide—leprosy	0.00166	0.0126	CcSEcCtD
Methotrexate—Skin exfoliation—Dapsone—leprosy	0.00161	0.0122	CcSEcCtD
Methotrexate—GGH—skin of body—leprosy	0.00155	0.0187	CbGeAlD
Methotrexate—ATIC—eye—leprosy	0.00151	0.0182	CbGeAlD
Methotrexate—Febrile neutropenia—Thalidomide—leprosy	0.00144	0.0109	CcSEcCtD
Methotrexate—Deep vein thrombosis—Thalidomide—leprosy	0.00142	0.0108	CcSEcCtD
Methotrexate—ABCC11—testis—leprosy	0.00141	0.017	CbGeAlD
Methotrexate—Psoriasis—Thalidomide—leprosy	0.00137	0.0104	CcSEcCtD
Methotrexate—FPGS—skin of body—leprosy	0.00136	0.0164	CbGeAlD
Methotrexate—Embolism—Thalidomide—leprosy	0.00134	0.0102	CcSEcCtD
Methotrexate—Nail disorder—Thalidomide—leprosy	0.00133	0.0101	CcSEcCtD
Methotrexate—ATIC—skin of body—leprosy	0.00132	0.0159	CbGeAlD
Methotrexate—SLC19A1—testis—leprosy	0.00129	0.0155	CbGeAlD
Methotrexate—Liver disorder—Thalidomide—leprosy	0.00127	0.00962	CcSEcCtD
Methotrexate—SLC19A1—nervous system—leprosy	0.00126	0.0152	CbGeAlD
Methotrexate—Burning sensation—Thalidomide—leprosy	0.00124	0.00944	CcSEcCtD
Methotrexate—Lung disorder—Thalidomide—leprosy	0.00122	0.00927	CcSEcCtD
Methotrexate—Cyanosis—Thalidomide—leprosy	0.00122	0.00927	CcSEcCtD
Methotrexate—Interstitial lung disease—Thalidomide—leprosy	0.00122	0.00927	CcSEcCtD
Methotrexate—SLC46A1—tendon—leprosy	0.0012	0.0144	CbGeAlD
Methotrexate—GGH—tendon—leprosy	0.00118	0.0142	CbGeAlD
Methotrexate—Stupor—Thalidomide—leprosy	0.00116	0.00879	CcSEcCtD
Methotrexate—Pleural effusion—Thalidomide—leprosy	0.00113	0.00857	CcSEcCtD
Methotrexate—MTHFR—eye—leprosy	0.00112	0.0136	CbGeAlD
Methotrexate—Skin ulcer—Thalidomide—leprosy	0.00111	0.00843	CcSEcCtD
Methotrexate—Petechiae—Thalidomide—leprosy	0.00105	0.00797	CcSEcCtD
Methotrexate—Pancreatitis—Dapsone—leprosy	0.00104	0.00788	CcSEcCtD
Methotrexate—FPGS—tendon—leprosy	0.00104	0.0125	CbGeAlD
Methotrexate—Apnoea—Thalidomide—leprosy	0.00102	0.00774	CcSEcCtD
Methotrexate—DHFR—eye—leprosy	0.00102	0.0122	CbGeAlD
Methotrexate—SLC46A1—testis—leprosy	0.000991	0.012	CbGeAlD
Methotrexate—Proteinuria—Thalidomide—leprosy	0.000983	0.00747	CcSEcCtD
Methotrexate—PGD—eye—leprosy	0.000976	0.0118	CbGeAlD
Methotrexate—GGH—testis—leprosy	0.000975	0.0118	CbGeAlD
Methotrexate—SLC46A1—nervous system—leprosy	0.000973	0.0117	CbGeAlD
Methotrexate—Protein urine present—Thalidomide—leprosy	0.000969	0.00736	CcSEcCtD
Methotrexate—Photosensitivity reaction—Dapsone—leprosy	0.000966	0.00734	CcSEcCtD
Methotrexate—Musculoskeletal stiffness—Thalidomide—leprosy	0.000962	0.00731	CcSEcCtD
Methotrexate—GGH—nervous system—leprosy	0.000957	0.0115	CbGeAlD
Methotrexate—Skin discolouration—Thalidomide—leprosy	0.000956	0.00726	CcSEcCtD
Methotrexate—Bone disorder—Thalidomide—leprosy	0.000956	0.00726	CcSEcCtD
Methotrexate—Hyperbilirubinaemia—Thalidomide—leprosy	0.000949	0.00721	CcSEcCtD
Methotrexate—Oliguria—Thalidomide—leprosy	0.000937	0.00712	CcSEcCtD
Methotrexate—Herpes simplex—Thalidomide—leprosy	0.000937	0.00712	CcSEcCtD
Methotrexate—Hyperuricaemia—Thalidomide—leprosy	0.000931	0.00707	CcSEcCtD
Methotrexate—SLC16A1—eye—leprosy	0.000911	0.011	CbGeAlD
Methotrexate—TYMS—skin of body—leprosy	0.000892	0.0108	CbGeAlD
Methotrexate—Blood uric acid increased—Thalidomide—leprosy	0.000879	0.00668	CcSEcCtD
Methotrexate—Pulmonary embolism—Thalidomide—leprosy	0.000863	0.00656	CcSEcCtD
Methotrexate—AOX1—eye—leprosy	0.00086	0.0104	CbGeAlD
Methotrexate—FPGS—testis—leprosy	0.000857	0.0103	CbGeAlD
Methotrexate—PGD—skin of body—leprosy	0.000849	0.0102	CbGeAlD
Methotrexate—FPGS—nervous system—leprosy	0.000841	0.0101	CbGeAlD
Methotrexate—Pharyngitis—Dapsone—leprosy	0.000841	0.00639	CcSEcCtD
Methotrexate—Depressed level of consciousness—Thalidomide—leprosy	0.000834	0.00633	CcSEcCtD
Methotrexate—ATIC—testis—leprosy	0.000829	0.01	CbGeAlD
Methotrexate—Skin exfoliation—Thalidomide—leprosy	0.000824	0.00626	CcSEcCtD
Methotrexate—ATIC—nervous system—leprosy	0.000814	0.00981	CbGeAlD
Methotrexate—Aplastic anaemia—Thalidomide—leprosy	0.000811	0.00616	CcSEcCtD
Methotrexate—Tinnitus—Dapsone—leprosy	0.00079	0.006	CcSEcCtD
Methotrexate—Gynaecomastia—Thalidomide—leprosy	0.000772	0.00587	CcSEcCtD
Methotrexate—Pulmonary oedema—Thalidomide—leprosy	0.000769	0.00584	CcSEcCtD
Methotrexate—Sepsis—Thalidomide—leprosy	0.000749	0.00569	CcSEcCtD
Methotrexate—Erythema—Dapsone—leprosy	0.000737	0.0056	CcSEcCtD
Methotrexate—Lymphadenopathy—Thalidomide—leprosy	0.000735	0.00558	CcSEcCtD
Methotrexate—SLCO3A1—tendon—leprosy	0.000732	0.00883	CbGeAlD
Methotrexate—Thrombophlebitis—Thalidomide—leprosy	0.000724	0.0055	CcSEcCtD
Methotrexate—Diabetes mellitus—Thalidomide—leprosy	0.000721	0.00548	CcSEcCtD
Methotrexate—Photosensitivity—Thalidomide—leprosy	0.000714	0.00542	CcSEcCtD
Methotrexate—Vision blurred—Dapsone—leprosy	0.000695	0.00528	CcSEcCtD
Methotrexate—SLCO1C1—testis—leprosy	0.000689	0.00831	CbGeAlD
Methotrexate—SLC22A8—eye—leprosy	0.000689	0.00831	CbGeAlD
Methotrexate—TYMS—tendon—leprosy	0.000679	0.00819	CbGeAlD
Methotrexate—Renal failure acute—Thalidomide—leprosy	0.000679	0.00516	CcSEcCtD
Methotrexate—SLCO1C1—nervous system—leprosy	0.000676	0.00816	CbGeAlD
Methotrexate—DHFR—tendon—leprosy	0.000672	0.00811	CbGeAlD
Methotrexate—Dermatitis exfoliative—Thalidomide—leprosy	0.000664	0.00505	CcSEcCtD
Methotrexate—Vertigo—Dapsone—leprosy	0.000662	0.00503	CcSEcCtD
Methotrexate—Visual disturbance—Thalidomide—leprosy	0.000661	0.00503	CcSEcCtD
Methotrexate—SLC22A7—testis—leprosy	0.000653	0.00788	CbGeAlD
Methotrexate—PGD—tendon—leprosy	0.000646	0.0078	CbGeAlD
Methotrexate—Cough—Dapsone—leprosy	0.000643	0.00489	CcSEcCtD
Methotrexate—Cerebrovascular accident—Thalidomide—leprosy	0.00064	0.00486	CcSEcCtD
Methotrexate—Lethargy—Thalidomide—leprosy	0.00064	0.00486	CcSEcCtD
Methotrexate—Osteoarthritis—Thalidomide—leprosy	0.000627	0.00476	CcSEcCtD
Methotrexate—MTHFR—testis—leprosy	0.000616	0.00743	CbGeAlD
Methotrexate—SLCO3A1—testis—leprosy	0.000606	0.00731	CbGeAlD
Methotrexate—MTHFR—nervous system—leprosy	0.000605	0.00729	CbGeAlD
Methotrexate—SLC16A1—tendon—leprosy	0.000603	0.00728	CbGeAlD
Methotrexate—SLCO3A1—nervous system—leprosy	0.000595	0.00718	CbGeAlD
Methotrexate—Mood swings—Thalidomide—leprosy	0.000594	0.00451	CcSEcCtD
Methotrexate—Ataxia—Thalidomide—leprosy	0.000589	0.00448	CcSEcCtD
Methotrexate—Liver function test abnormal—Thalidomide—leprosy	0.000579	0.0044	CcSEcCtD
Methotrexate—AOX1—tendon—leprosy	0.000569	0.00687	CbGeAlD
Methotrexate—Breast disorder—Thalidomide—leprosy	0.000566	0.0043	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000564	0.00429	CcSEcCtD
Methotrexate—TYMS—testis—leprosy	0.000562	0.00678	CbGeAlD
Methotrexate—DHFR—testis—leprosy	0.000557	0.00671	CbGeAlD
Methotrexate—ABCC10—tendon—leprosy	0.000554	0.00669	CbGeAlD
Methotrexate—TYMS—nervous system—leprosy	0.000552	0.00666	CbGeAlD
Methotrexate—DHFR—nervous system—leprosy	0.000546	0.00659	CbGeAlD
Methotrexate—Insomnia—Dapsone—leprosy	0.000544	0.00414	CcSEcCtD
Methotrexate—Eosinophilia—Thalidomide—leprosy	0.000536	0.00408	CcSEcCtD
Methotrexate—PGD—testis—leprosy	0.000535	0.00646	CbGeAlD
Methotrexate—Pancreatitis—Thalidomide—leprosy	0.000531	0.00404	CcSEcCtD
Methotrexate—PGD—nervous system—leprosy	0.000525	0.00634	CbGeAlD
Methotrexate—Pancytopenia—Thalidomide—leprosy	0.000514	0.00391	CcSEcCtD
Methotrexate—Neutropenia—Thalidomide—leprosy	0.000507	0.00385	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Thalidomide—leprosy	0.000503	0.00383	CcSEcCtD
Methotrexate—SLC16A1—testis—leprosy	0.0005	0.00603	CbGeAlD
Methotrexate—Erectile dysfunction—Thalidomide—leprosy	0.000499	0.00379	CcSEcCtD
Methotrexate—Photosensitivity reaction—Thalidomide—leprosy	0.000494	0.00376	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dapsone—leprosy	0.000492	0.00374	CcSEcCtD
Methotrexate—SLC16A1—nervous system—leprosy	0.00049	0.00591	CbGeAlD
Methotrexate—Pneumonia—Thalidomide—leprosy	0.000486	0.00369	CcSEcCtD
Methotrexate—Infestation NOS—Thalidomide—leprosy	0.000483	0.00367	CcSEcCtD
Methotrexate—Infestation—Thalidomide—leprosy	0.000483	0.00367	CcSEcCtD
Methotrexate—Drowsiness—Thalidomide—leprosy	0.000483	0.00367	CcSEcCtD
Methotrexate—Depression—Thalidomide—leprosy	0.000482	0.00366	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000479	0.00364	CcSEcCtD
Methotrexate—Body temperature increased—Dapsone—leprosy	0.000476	0.00361	CcSEcCtD
Methotrexate—Abdominal pain—Dapsone—leprosy	0.000476	0.00361	CcSEcCtD
Methotrexate—Renal failure—Thalidomide—leprosy	0.000475	0.00361	CcSEcCtD
Methotrexate—AOX1—testis—leprosy	0.000471	0.00569	CbGeAlD
Methotrexate—Stomatitis—Thalidomide—leprosy	0.000471	0.00358	CcSEcCtD
Methotrexate—Conjunctivitis—Thalidomide—leprosy	0.000469	0.00357	CcSEcCtD
Methotrexate—Sweating—Thalidomide—leprosy	0.000463	0.00352	CcSEcCtD
Methotrexate—ABCC3—testis—leprosy	0.000461	0.00556	CbGeAlD
Methotrexate—Haematuria—Thalidomide—leprosy	0.000461	0.0035	CcSEcCtD
Methotrexate—ABCC4—tendon—leprosy	0.00046	0.00555	CbGeAlD
Methotrexate—ABCC10—testis—leprosy	0.000459	0.00554	CbGeAlD
Methotrexate—Epistaxis—Thalidomide—leprosy	0.000456	0.00346	CcSEcCtD
Methotrexate—ABCB1—blood vessel—leprosy	0.000454	0.00548	CbGeAlD
Methotrexate—ABCC3—nervous system—leprosy	0.000453	0.00546	CbGeAlD
Methotrexate—Agranulocytosis—Thalidomide—leprosy	0.000451	0.00342	CcSEcCtD
Methotrexate—ABCC2—tendon—leprosy	0.000445	0.00537	CbGeAlD
Methotrexate—Hepatitis—Thalidomide—leprosy	0.000434	0.00329	CcSEcCtD
Methotrexate—Pharyngitis—Thalidomide—leprosy	0.00043	0.00327	CcSEcCtD
Methotrexate—Urinary tract disorder—Thalidomide—leprosy	0.000428	0.00325	CcSEcCtD
Methotrexate—Urethral disorder—Thalidomide—leprosy	0.000425	0.00323	CcSEcCtD
Methotrexate—Visual impairment—Thalidomide—leprosy	0.000418	0.00317	CcSEcCtD
Methotrexate—Erythema multiforme—Thalidomide—leprosy	0.00041	0.00312	CcSEcCtD
Methotrexate—Eye disorder—Thalidomide—leprosy	0.000405	0.00308	CcSEcCtD
Methotrexate—Tinnitus—Thalidomide—leprosy	0.000404	0.00307	CcSEcCtD
Methotrexate—Cardiac disorder—Thalidomide—leprosy	0.000402	0.00306	CcSEcCtD
Methotrexate—SLCO1A2—testis—leprosy	0.000396	0.00477	CbGeAlD
Methotrexate—Angiopathy—Thalidomide—leprosy	0.000393	0.00299	CcSEcCtD
Methotrexate—ALB—testis—leprosy	0.000393	0.00474	CbGeAlD
Methotrexate—ABCC1—tendon—leprosy	0.000392	0.00473	CbGeAlD
Methotrexate—Immune system disorder—Thalidomide—leprosy	0.000392	0.00298	CcSEcCtD
Methotrexate—Mediastinal disorder—Thalidomide—leprosy	0.000391	0.00297	CcSEcCtD
Methotrexate—Chills—Thalidomide—leprosy	0.000389	0.00296	CcSEcCtD
Methotrexate—SLCO1A2—nervous system—leprosy	0.000388	0.00468	CbGeAlD
Methotrexate—Alopecia—Thalidomide—leprosy	0.000383	0.00291	CcSEcCtD
Methotrexate—Vomiting—Dapsone—leprosy	0.000383	0.00291	CcSEcCtD
Methotrexate—ABCC4—testis—leprosy	0.000381	0.00459	CbGeAlD
Methotrexate—Mental disorder—Thalidomide—leprosy	0.00038	0.00289	CcSEcCtD
Methotrexate—Malnutrition—Thalidomide—leprosy	0.000377	0.00287	CcSEcCtD
Methotrexate—Headache—Dapsone—leprosy	0.000377	0.00286	CcSEcCtD
Methotrexate—ABCC4—nervous system—leprosy	0.000374	0.00451	CbGeAlD
Methotrexate—SLC22A8—nervous system—leprosy	0.000371	0.00447	CbGeAlD
Methotrexate—Dysgeusia—Thalidomide—leprosy	0.00037	0.00281	CcSEcCtD
Methotrexate—ABCC2—testis—leprosy	0.000368	0.00444	CbGeAlD
Methotrexate—Back pain—Thalidomide—leprosy	0.000365	0.00277	CcSEcCtD
Methotrexate—Nausea—Dapsone—leprosy	0.000357	0.00272	CcSEcCtD
Methotrexate—Vision blurred—Thalidomide—leprosy	0.000356	0.0027	CcSEcCtD
Methotrexate—Ill-defined disorder—Thalidomide—leprosy	0.00035	0.00266	CcSEcCtD
Methotrexate—Anaemia—Thalidomide—leprosy	0.000349	0.00265	CcSEcCtD
Methotrexate—Malaise—Thalidomide—leprosy	0.00034	0.00259	CcSEcCtD
Methotrexate—Vertigo—Thalidomide—leprosy	0.000339	0.00258	CcSEcCtD
Methotrexate—Leukopenia—Thalidomide—leprosy	0.000338	0.00257	CcSEcCtD
Methotrexate—Cough—Thalidomide—leprosy	0.000329	0.0025	CcSEcCtD
Methotrexate—Convulsion—Thalidomide—leprosy	0.000327	0.00248	CcSEcCtD
Methotrexate—ABCC1—testis—leprosy	0.000325	0.00392	CbGeAlD
Methotrexate—Arthralgia—Thalidomide—leprosy	0.000321	0.00244	CcSEcCtD
Methotrexate—Chest pain—Thalidomide—leprosy	0.000321	0.00244	CcSEcCtD
Methotrexate—Myalgia—Thalidomide—leprosy	0.000321	0.00244	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000319	0.00242	CcSEcCtD
Methotrexate—Discomfort—Thalidomide—leprosy	0.000317	0.00241	CcSEcCtD
Methotrexate—Confusional state—Thalidomide—leprosy	0.000311	0.00236	CcSEcCtD
Methotrexate—Infection—Thalidomide—leprosy	0.000306	0.00233	CcSEcCtD
Methotrexate—Nervous system disorder—Thalidomide—leprosy	0.000302	0.0023	CcSEcCtD
Methotrexate—Thrombocytopenia—Thalidomide—leprosy	0.000302	0.00229	CcSEcCtD
Methotrexate—Skin disorder—Thalidomide—leprosy	0.000299	0.00227	CcSEcCtD
Methotrexate—Hyperhidrosis—Thalidomide—leprosy	0.000298	0.00226	CcSEcCtD
Methotrexate—Anorexia—Thalidomide—leprosy	0.000294	0.00223	CcSEcCtD
Methotrexate—Hypotension—Thalidomide—leprosy	0.000288	0.00219	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Thalidomide—leprosy	0.000281	0.00213	CcSEcCtD
Methotrexate—Insomnia—Thalidomide—leprosy	0.000279	0.00212	CcSEcCtD
Methotrexate—Paraesthesia—Thalidomide—leprosy	0.000277	0.0021	CcSEcCtD
Methotrexate—Dyspnoea—Thalidomide—leprosy	0.000275	0.00209	CcSEcCtD
Methotrexate—Somnolence—Thalidomide—leprosy	0.000274	0.00208	CcSEcCtD
Methotrexate—Dyspepsia—Thalidomide—leprosy	0.000271	0.00206	CcSEcCtD
Methotrexate—ABCG2—testis—leprosy	0.000269	0.00324	CbGeAlD
Methotrexate—Decreased appetite—Thalidomide—leprosy	0.000268	0.00203	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Thalidomide—leprosy	0.000266	0.00202	CcSEcCtD
Methotrexate—Fatigue—Thalidomide—leprosy	0.000266	0.00202	CcSEcCtD
Methotrexate—Pain—Thalidomide—leprosy	0.000263	0.002	CcSEcCtD
Methotrexate—Feeling abnormal—Thalidomide—leprosy	0.000254	0.00193	CcSEcCtD
Methotrexate—Gastrointestinal pain—Thalidomide—leprosy	0.000252	0.00191	CcSEcCtD
Methotrexate—Urticaria—Thalidomide—leprosy	0.000245	0.00186	CcSEcCtD
Methotrexate—Body temperature increased—Thalidomide—leprosy	0.000244	0.00185	CcSEcCtD
Methotrexate—Abdominal pain—Thalidomide—leprosy	0.000244	0.00185	CcSEcCtD
Methotrexate—Hypersensitivity—Thalidomide—leprosy	0.000227	0.00172	CcSEcCtD
Methotrexate—Asthenia—Thalidomide—leprosy	0.000221	0.00168	CcSEcCtD
Methotrexate—Pruritus—Thalidomide—leprosy	0.000218	0.00166	CcSEcCtD
Methotrexate—Diarrhoea—Thalidomide—leprosy	0.000211	0.0016	CcSEcCtD
Methotrexate—Dizziness—Thalidomide—leprosy	0.000204	0.00155	CcSEcCtD
Methotrexate—Vomiting—Thalidomide—leprosy	0.000196	0.00149	CcSEcCtD
Methotrexate—Rash—Thalidomide—leprosy	0.000194	0.00148	CcSEcCtD
Methotrexate—Dermatitis—Thalidomide—leprosy	0.000194	0.00147	CcSEcCtD
Methotrexate—Headache—Thalidomide—leprosy	0.000193	0.00147	CcSEcCtD
Methotrexate—Nausea—Thalidomide—leprosy	0.000183	0.00139	CcSEcCtD
Methotrexate—ABCB1—testis—leprosy	0.000133	0.0016	CbGeAlD
Methotrexate—ABCB1—nervous system—leprosy	0.00013	0.00157	CbGeAlD
Methotrexate—FOLR1—Folate Metabolism—IFNG—leprosy	8.45e-06	0.0762	CbGpPWpGaD
Methotrexate—FOLR1—Folate Metabolism—IL2—leprosy	7.51e-06	0.0677	CbGpPWpGaD
Methotrexate—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHD—leprosy	5.98e-06	0.054	CbGpPWpGaD
Methotrexate—FOLR1—Folate Metabolism—TNF—leprosy	5.47e-06	0.0493	CbGpPWpGaD
Methotrexate—SLC19A1—Folate Metabolism—IFNG—leprosy	3.36e-06	0.0303	CbGpPWpGaD
Methotrexate—SLC19A1—Folate Metabolism—IL2—leprosy	2.99e-06	0.027	CbGpPWpGaD
Methotrexate—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	2.48e-06	0.0224	CbGpPWpGaD
Methotrexate—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	2.43e-06	0.0219	CbGpPWpGaD
Methotrexate—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SDHD—leprosy	2.32e-06	0.0209	CbGpPWpGaD
Methotrexate—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	2.25e-06	0.0203	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—IFNG—leprosy	2.23e-06	0.0201	CbGpPWpGaD
Methotrexate—SLC19A1—Folate Metabolism—TNF—leprosy	2.18e-06	0.0196	CbGpPWpGaD
Methotrexate—SLCO3A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	2.15e-06	0.0194	CbGpPWpGaD
Methotrexate—SLCO4C1—SLC-mediated transmembrane transport—SLC11A1—leprosy	2.05e-06	0.0185	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—IL2—leprosy	1.98e-06	0.0179	CbGpPWpGaD
Methotrexate—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	1.89e-06	0.0171	CbGpPWpGaD
Methotrexate—ABCC11—Transmembrane transport of small molecules—SLC11A1—leprosy	1.74e-06	0.0157	CbGpPWpGaD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.72e-06	0.0155	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—IFNG—leprosy	1.65e-06	0.0149	CbGpPWpGaD
Methotrexate—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	1.58e-06	0.0142	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—TNF—leprosy	1.44e-06	0.013	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IFNG—leprosy	1.34e-06	0.0121	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IFNG—leprosy	1.19e-06	0.0108	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—IL2—leprosy	1.19e-06	0.0108	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.15e-06	0.0104	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—SLC11A1—leprosy	1.15e-06	0.0104	CbGpPWpGaD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.13e-06	0.0102	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.11e-06	0.00997	CbGpPWpGaD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.09e-06	0.00984	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—SDHD—leprosy	1.08e-06	0.00976	CbGpPWpGaD
Methotrexate—MTHFR—Vitamin B12 Metabolism—TNF—leprosy	1.07e-06	0.00964	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—IFNG—leprosy	1.07e-06	0.00963	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—IL2—leprosy	1.06e-06	0.00957	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.04e-06	0.00939	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—leprosy	1.02e-06	0.00923	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—leprosy	9.72e-07	0.00877	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—SLC11A1—leprosy	9.71e-07	0.00876	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SDHD—leprosy	9.2e-07	0.0083	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—SDHD—leprosy	9.2e-07	0.0083	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC11A1—leprosy	8.72e-07	0.00787	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TNF—leprosy	8.7e-07	0.00785	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—leprosy	8.6e-07	0.00776	CbGpPWpGaD
Methotrexate—FPGS—Disease—SLC11A1—leprosy	8.26e-07	0.00745	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TNF—leprosy	7.73e-07	0.00697	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	7.63e-07	0.00689	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	7.18e-07	0.00647	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SDHD—leprosy	7.17e-07	0.00647	CbGpPWpGaD
Methotrexate—MTHFR—Selenium Micronutrient Network—TNF—leprosy	6.91e-07	0.00623	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SDHD—leprosy	6.56e-07	0.00591	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—leprosy	6.53e-07	0.00589	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SLC11A1—leprosy	6.43e-07	0.0058	CbGpPWpGaD
Methotrexate—PGD—Disease—SLC11A1—leprosy	5.88e-07	0.00531	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC11A1—leprosy	5.73e-07	0.00517	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC11A1—leprosy	5.62e-07	0.00507	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC11A1—leprosy	5.2e-07	0.00469	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—leprosy	4.94e-07	0.00445	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL10—leprosy	4.74e-07	0.00427	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—CD40LG—leprosy	4.74e-07	0.00427	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IFNG—leprosy	4.51e-07	0.00407	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC11A1—leprosy	4.46e-07	0.00402	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC11A1—leprosy	4.37e-07	0.00394	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SDHD—leprosy	4.33e-07	0.0039	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SDHD—leprosy	4.23e-07	0.00381	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC11A1—leprosy	4.19e-07	0.00378	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SLC11A1—leprosy	3.88e-07	0.0035	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—leprosy	3.88e-07	0.0035	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SDHD—leprosy	3.84e-07	0.00347	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	3.81e-07	0.00344	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC11A1—leprosy	3.79e-07	0.00342	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC11A1—leprosy	3.73e-07	0.00336	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IFNG—leprosy	3.67e-07	0.00331	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	3.65e-07	0.00329	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC11A1—leprosy	3.53e-07	0.00319	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SDHD—leprosy	3.5e-07	0.00316	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.49e-07	0.00315	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC11A1—leprosy	3.45e-07	0.00311	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SDHD—leprosy	3.35e-07	0.00303	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.32e-07	0.00299	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL2—leprosy	3.26e-07	0.00294	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—CD4—leprosy	3.08e-07	0.00278	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SDHD—leprosy	3.08e-07	0.00278	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	3.07e-07	0.00277	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—TNF—leprosy	2.92e-07	0.00263	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IFNG—leprosy	2.92e-07	0.00263	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.88e-07	0.0026	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IFNG—leprosy	2.78e-07	0.00251	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SDHD—leprosy	2.78e-07	0.0025	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—IL2—leprosy	2.74e-07	0.00247	CbGpPWpGaD
Methotrexate—FPGS—Disease—CD4—leprosy	2.62e-07	0.00236	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—leprosy	2.47e-07	0.00223	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SDHD—leprosy	2.42e-07	0.00218	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—leprosy	2.38e-07	0.00214	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SDHD—leprosy	2.18e-07	0.00196	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SDHD—leprosy	2.07e-07	0.00186	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—leprosy	2.04e-07	0.00184	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC11A1—leprosy	1.95e-07	0.00176	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SDHD—leprosy	1.91e-07	0.00173	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	1.9e-07	0.00171	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—leprosy	1.89e-07	0.00171	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—leprosy	1.89e-07	0.0017	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—leprosy	1.87e-07	0.00168	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—leprosy	1.8e-07	0.00163	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.66e-07	0.0015	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—leprosy	1.41e-07	0.00127	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	1.24e-07	0.00112	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—leprosy	1.23e-07	0.00111	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—leprosy	1.2e-07	0.00109	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SDHD—leprosy	1.18e-07	0.00107	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—leprosy	1.09e-07	0.000987	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SDHD—leprosy	1.03e-07	0.000934	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	8.89e-08	0.000802	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—leprosy	6.39e-08	0.000577	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—leprosy	6.2e-08	0.000559	CbGpPWpGaD
